These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18665851)

  • 1. Transient focal cerebral ischaemia and bilateral pulmonary embolism after desmopressin treatment for von Willebrand's disease.
    de Wee EM; Ikram MK; Dippel DW; Leebeek FW
    Haemophilia; 2008 Sep; 14(5):1133-4. PubMed ID: 18665851
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmopressin--a nontransfusional form of prevention of postextractive bleeding in some patients with von Willebrand's type I disease. Case report.
    Rahnama M; Tomaszewski T; Swiatkowski W
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):150-3. PubMed ID: 12898917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyponatremia during therapy of von Willebrand's disease. A life threatening complication after desmopressin (Minitrin) infusion].
    Brinch LJ; Jacobsen MB
    Tidsskr Nor Laegeforen; 1992 Nov; 112(29):3670-1. PubMed ID: 1471128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease.
    Bertholini DM; Butler CS
    Anaesth Intensive Care; 2000 Apr; 28(2):199-201. PubMed ID: 10788975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Venous thrombosis of the lower limbs and pulmonary embolism after desmopressin: a coincidence or a pathogenetic role?].
    Pentimone F; Del Corso L
    Clin Ter; 1991 Oct 15-31; 139(1-2):49-51. PubMed ID: 1837767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDAVP for von Willebrand menorrhagia--severe hyponatraemia, haemolysis, seizure, coma.!! Caution.
    Olowokure O; Fishman M; Cromwell C; Aledort L
    Haemophilia; 2009 May; 15(3):837. PubMed ID: 19432930
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of desmopressin in the treatment of mild forms of hemophilia A and von Willebrand's disease].
    Vicente V; Alegre A; Alberca I
    Med Clin (Barc); 1987 Mar; 88(9):353-5. PubMed ID: 3494893
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders.
    Cattaneo M
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():10-4; discussion 14-8. PubMed ID: 9088829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PFA-100 testing for pretherapeutic assessment of response to DDAVP in patients with von Willebrand's disease.
    Weston H; Just S; Williams B; Rowell J; Kennedy GA
    Haemophilia; 2009 Jan; 15(1):372-3. PubMed ID: 19149861
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment with desmopressin before epidural anesthesia in a patient with type I von Willebrand disease].
    Pérez-Barrero P; Gil L; Martínez C; Bueno AB; Casado AI; Oro J
    Rev Esp Anestesiol Reanim; 2003 Dec; 50(10):526-9. PubMed ID: 14737779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Von Willebrand Working Party of the United Kingdom Haemophilia Centre Director's Organization.
    Lethagen S; Flordal P; Van Aken H; Hunt BJ; Cattaneo M
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():19-22. PubMed ID: 9088830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common bleeding disorders: a potential catastrophe for the trauma victim. Therapeutic recommendations for the treatment of von Willebrand's disease.
    Slam K; Zyromski N; Nowicki P; Serrano P; Purtill MA
    J Trauma; 2008 May; 64(5):1373-5. PubMed ID: 18469664
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the PFA-100 system for monitoring desmopressin therapy in patients with type 1 von Willebrand's disease.
    Franchini M; Gandini G; Manzato F; Lippi G
    Haematologica; 2002 Jun; 87(6):670. PubMed ID: 12031931
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
    Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
    Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hemophilia A and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP].
    Ingerslev J; Christiansen SE; Kristensen T; Wallevik K; Bernvil SS
    Ugeskr Laeger; 1985 Nov; 147(45):3592-4. PubMed ID: 3907076
    [No Abstract]   [Full Text] [Related]  

  • 16. New approach of the treatment of von Willebrand's disease during pregnancy.
    Gojnic M; Fazlagic A; Likic I; Stefanovic A; Vidakovic S; Pervulov M; Petkovic S; Mostic T; Miljic P; Bogdanovic A
    Arch Gynecol Obstet; 2005 Nov; 273(1):35-8. PubMed ID: 16172853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of both normal and bleeding patients is indicated before desmopressin administration.
    Girolami A; Vettore S; Fabris F
    Thromb Haemost; 2005 Jun; 93(6):1198. PubMed ID: 15968410
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease.
    Kavakli K; Polat A; Hüseyinof A; Nisli G; Aydinok Y
    Thromb Haemost; 1999 Apr; 81(4):665-6. PubMed ID: 10235463
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L; Boggio L; Green D
    Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for the diagnosis and management of von Willebrand's disease.
    Cattaneo M; Hunt BJ; Van Aken H; Flordal PA; Lethagen S
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():23. PubMed ID: 9088831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.